These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15246023)

  • 1. New insights into the pathogenesis of dilated cardiomyopathy: possible underlying autoimmune mechanisms and therapy.
    Mobini R; Maschke H; Waagstein F
    Autoimmun Rev; 2004 Jun; 3(4):277-84. PubMed ID: 15246023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoadsorption as treatment option in dilated cardiomyopathy.
    Felix SB; Staudt A
    Autoimmunity; 2008 Sep; 41(6):484-9. PubMed ID: 18781476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory dilated cardiomyopathy (DCMI).
    Maisch B; Richter A; Sandmöller A; Portig I; Pankuweit S;
    Herz; 2005 Sep; 30(6):535-44. PubMed ID: 16170686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoadsorption in dilated cardiomyopathy.
    Staudt A; Felix SB
    Transfus Apher Sci; 2007 Oct; 37(2):187-90. PubMed ID: 18036989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-specific immunoadsorption in patients with dilated cardiomyopathy: mechanisms and clinical effects.
    Felix SB; Staudt A
    Int J Cardiol; 2006 Sep; 112(1):30-3. PubMed ID: 16860418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of β₁-adrenoceptor autoantibodies in the pathogenesis of dilated cardiomyopathy.
    Dandel M; Wallukat G; Potapov E; Hetzer R
    Immunobiology; 2012 May; 217(5):511-20. PubMed ID: 21820755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-heart autoantibodies in familial dilated cardiomyopathy.
    Caforio AL; Vinci A; Iliceto S
    Autoimmunity; 2008 Sep; 41(6):462-9. PubMed ID: 18781472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy.
    Caforio AL; Tona F; Bottaro S; Vinci A; Dequal G; Daliento L; Thiene G; Iliceto S
    Autoimmunity; 2008 Feb; 41(1):35-45. PubMed ID: 18176863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmunity and idiopathic dilated cardiomyopathy: where we stand?
    Fu M
    Autoimmunity; 2008 Sep; 41(6):415-8. PubMed ID: 18781466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoadsorption therapy for dilated cardiomyopathy and pulmonary arterial hypertension.
    Dandel M; Wallukat G; Englert A; Hetzer R
    Atheroscler Suppl; 2013 Jan; 14(1):203-11. PubMed ID: 23357166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of evidence for a pathogenic role of proteasome-directed autoimmunity in dilated cardiomyopathy.
    Voigt A; Trimpert C; Bartel K; Egerer K; Kuckelkorn U; Feist E; Gericke C; Klingel K; Kandolf R; Felix SB; Baumann G; Kloetzel PM; Stangl K; Staudt A
    Basic Res Cardiol; 2010 Jul; 105(4):557-67. PubMed ID: 20336303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammation in dilated cardiomyopathy.
    Pankuweit S; Ruppert V; Maisch B
    Herz; 2004 Dec; 29(8):788-93. PubMed ID: 15599676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral anti-proteasomal autoimmunity in dilated cardiomyopathy.
    Voigt A; Bartel K; Egerer K; Trimpert C; Feist E; Gericke C; Kandolf R; Klingel K; Kuckelkorn U; Stangl K; Felix SB; Baumann G; Kloetzel PM; Staudt A
    Basic Res Cardiol; 2010 Jan; 105(1):9-18. PubMed ID: 19760349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis and therapy of autoimmunity-induced dilated cardiomyopathy.
    Zhao P; Sharma AC; Ren J
    Front Biosci (Landmark Ed); 2009 Jan; 14(5):1708-15. PubMed ID: 19273156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoadsorption in dilated cardiomyopathy: long-term reduction of cardiodepressant antibodies.
    Trimpert C; Herda LR; Eckerle LG; Pohle S; Müller C; Landsberger M; Felix SB; Staudt A
    Eur J Clin Invest; 2010 Aug; 40(8):685-91. PubMed ID: 20546018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. beta(1)-Adrenergic receptor function, autoimmunity, and pathogenesis of dilated cardiomyopathy.
    Jahns R; Boivin V; Lohse MJ
    Trends Cardiovasc Med; 2006 Jan; 16(1):20-4. PubMed ID: 16387626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathological autoantibodies in cardiomyopathy.
    Jahns R; Boivin V; Schwarzbach V; Ertl G; Lohse MJ
    Autoimmunity; 2008 Sep; 41(6):454-61. PubMed ID: 18781471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetically determined myocarditis: clinical presentation and immunological characteristics.
    Caforio AL; Iliceto S
    Curr Opin Cardiol; 2008 May; 23(3):219-26. PubMed ID: 18382209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta 1-adrenergic receptor-directed autoimmunity as a cause of dilated cardiomyopathy in rats.
    Jahns R; Boivin V; Lohse MJ
    Int J Cardiol; 2006 Sep; 112(1):7-14. PubMed ID: 16872696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential role of antibodies against cardiac Kv channel-interacting protein 2 in dilated cardiomyopathy.
    Landsberger M; Staudt A; Choudhury S; Trimpert C; Herda LR; Klingel K; Kandolf R; Schultheiss HP; Kroemer HK; Völker U; Felix SB
    Am Heart J; 2008 Jul; 156(1):92-99.e2. PubMed ID: 18585502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.